",{"id":"SIGNIN"}).html('
×
').appendTo("body");jQuery("#SIGNIN").on('click',function(e){closeLogin()})},closeLogin=function(){jQuery("#SIGNIN").remove();jQuery("body").css("overflow","inherit")},adjustLoginHeight=function(h){jQuery("#Oframe").height(h)},login_success=function(sess){jQuery(".sign-up").html("LOGOUT").on('click',function(){location.href="https://signin."+DOMAIN+"/oauth/logout"});closeLogin()},LANG='en',commentHeight=function(data){jQuery("#block-ibt-comment iframe").height(data.height)};var login_success=function(sess){closeLogin();jQuery("article").removeClass("wall");jQuery(".login-btn .sign-up2").hide();jQuery(".login-btn .myaccount").show();jQuery(".only-before-login").hide();if(typeof sess=='object'){sess=sess.sess};jQuery("
",{"id":"TEMPE"}).html('').appendTo("body");jQuery("#TEMPE iframe").on("load",function(){jQuery("#TEMPE").remove();if(jQuery("iframe.comment").length){jQuery("iframe.comment").get(0).contentWindow.postMessage({'action':'success',},'*')}});afterLogin()};function afterLogin(){};doFir.push(function(){jQuery(document).ready(function(){jQuery(".sign-up2").on('click',function(e){e.preventDefault();e.stopPropagation();openLogin('https://signin.'+DOMAIN.replace(/ibtimes\.[\.a-z]+/,'ibtimes.com')+'/oauth?l='+jQuery(this).attr('data-lang'))})})})
A new drug developed by Merck shows promise for the treatment of Alzheimer’s disease. Verubecestat, which is currently under clinical trial, is said to halt the beta amyloid plaque formation in brain.